Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 87

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 87
---
 shares, which are listed on the
Nasdaq Capital Market. Any underwriters to whom securities are sold for public offering and sale may make a market in the securities,
but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. The securities,
other than our ordinary shares, may or may not be listed on a national securities exchange.

<div align='center'>23

TAXATION</div>

Material tax consequences
relating to the purchase, ownership and disposition of any of the securities registered by this prospectus will be set forth in the applicable
prospectus supplement(s) relating to the offering of such securities.

<div align='center'>EXPENSES OF THE OFFERING</div>

The following table sets
forth the expenses (other than underwriting discounts and commissions or agency fees and other items constituting underwriters’
or agents’ compensation, if any) expected to be incurred by us in connection with a possible offering of the securities registered
under the registration statement of which this prospectus forms a part.

| SEC Registration Fee             |     | $ | 22,040 |
| FINRA filing fee                 |     |   | 30,500 |
| Legal fees and expenses          |     |   |      * |
| Accountants’ fees and expenses   |     |   |      * |
| Printing expenses                |     |   |      * |
| Transfer agent fees and expenses |     |   |      * |
| Miscellaneous                    |     |   |      * |
| Total                            |     |   |      * |

| * | Estimated fees and expenses are not presently known. If                                  
 required, to be provided by a prospectus supplement or as an exhibit to a Current Report 
 on Form 6-K that is incorporated by reference into this prospectus.                      |

<div align='center'>LEGAL MATTERS</div>

Certain legal matters with
respect to Israeli law and with respect to the validity of the offered securities under Israeli law will be passed upon for us by Meitar
| Law Offices, Ramat Gan, Israel.Certain legal matters with respect to U.S. law will be passed upon for us by Latham &
Watkins LLP, New York, New York.

<div align='center'>EXPERTS</div>

The financial statements
incorporated in this prospectus by reference to the Annual Report on Form 20-F for the year ended December 31, 2022 have been so incorporated
in